CLQ

N4-(7-CHLORO-QUINOLIN-4-YL)-N1,N1-DIETHYL-PENTANE-1,4-DIAMINE

Created:	1999-07-08
Last modified:	2021-03-01

Find Related PDB Entry
5 entries where CLQ is found as a standalone ligand

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	48
Chiral Atom Count	1
Bond Count	49
Aromatic Bond Count	11

WebGL does not seem to be available.

This can be caused by an outdated browser, graphics card driver issue, or bad weather. Sometimes, just restarting the browser helps. Also, make sure hardware acceleration is enabled in your browser.

For a list of supported browsers, refer to http://caniuse.com/#feat=webgl.

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N4-(7-CHLORO-QUINOLIN-4-YL)-N1,N1-DIETHYL-PENTANE-1,4-DIAMINE
Synonyms	CHLOROQUINE
Systematic Name (OpenEye OEToolkits)	(4R)-N'-(7-chloroquinolin-4-yl)-N,N-diethyl-pentane-1,4-diamine
Formula	C₁₈ H₂₆ Cl N₃
Molecular Weight	319.872
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	Clc1cc2nccc(c2cc1)NC(C)CCCN(CC)CC
SMILES	CACTVS	3.341	CCN(CC)CCC[CH](C)Nc1ccnc2cc(Cl)ccc12
SMILES	OpenEye OEToolkits	1.5.0	CCN(CC)CCCC(C)Nc1ccnc2c1ccc(c2)Cl
Canonical SMILES	CACTVS	3.341	CCN(CC)CCC[C@@H](C)Nc1ccnc2cc(Cl)ccc12
Canonical SMILES	OpenEye OEToolkits	1.5.0	CCN(CC)CCC[C@@H](C)Nc1ccnc2c1ccc(c2)Cl
InChI	InChI	1.03	InChI=1S/C18H26ClN3/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21)/t14-/m1/s1
InChIKey	InChI	1.03	WHTVZRBIWZFKQO-CQSZACIVSA-N

Drug Info: DrugBank

DrugBank ID	DB00608
Name	Chloroquine
Groups	vet_approved approved investigational
Description	Chloroquine is an aminoquinolone derivative first developed in the 1940s for the treatment of malaria.[A191655] It was the drug of choice to treat malaria until the development of newer antimalarials such as [pyrimethamine], [artemisinin], and [mefloquine].[A191787] Chloroquine and its derivative [hydroxychloroquine] have since been repurposed for the treatment of a number of other conditions including HIV, systemic lupus erythematosus, and rheumatoid arthritis.[A192432] The FDA emergency use authorization for [hydroxychloroquine] and chloroquine in the treatment of COVID-19 was revoked on 15 June 2020.[L14312] Chloroquine was granted FDA Approval on 31 October 1949.[L12054]
Synonyms	Chloroquine sulfate Chloroquine phosphate Chloroquinium Chlorochin Chloroquinum Chloroquina N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine Chloroquine Chloroquine hydrochloride Chloraquine Cloroquina
Brand Names	Aralen Chloroquine phosphate Chloroquine Phosphate Teva-chloroquine Chloroquine
Indication	Chloroquine is indicated to treat infections of _P. vivax_, _P. malariae_, _P. ovale_, and susceptible strains of _P. falciparum_.[L12051] It is also used to treat extraintestinal amebiasis.[L12051] Chloroquine is also used off label for the treatment of rheumatic diseases,[A191655] as well as treatment and prophylaxis of Zika virus.[A191649,A191652] Chloroquine is currently undergoing clinical trials for the treatment of COVID-19.[A191631]
Categories	Agents Causing Muscle Toxicity Agents that produce neuromuscular block (indirect) Agents that reduce seizure threshold alpha-Galactosidase, antagonists & inhibitors Amebicides Aminoquinolines Analgesics Analgesics, Non-Narcotic Anti-Infective Agents Anti-Inflammatory Agents Antimalarials Antinematodal Agents Antiparasitic Agents Antiparasitic Products, Insecticides and Repellents Antiprotozoals Antirheumatic Agents Biguanides Central Nervous System Agents Cytochrome P-450 CYP2C8 Substrates Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP2D6 Inhibitors (moderate) Cytochrome P-450 CYP2D6 Substrates Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Drugs causing inadvertant photosensitivity Drugs that are Mainly Renally Excreted Experimental Unapproved Treatments for COVID-19 Filaricides Heterocyclic Compounds, Fused-Ring Methemoglobinemia Associated Agents Moderate Risk QTc-Prolonging Agents P-glycoprotein inhibitors P-glycoprotein substrates Peripheral Nervous System Agents Photosensitizing Agents QTc Prolonging Agents Quinolines Sensory System Agents Tumor Necrosis Factor Blockers
ATC-Code	P01BB52 P01BA01
CAS number	54-05-7

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Atypical chemokine receptor 1	MGNCLHRAELSPSTENSSQLDFEDVWNSSYGVNDSFPDGDYGANLEAAAP...	unknown	modulator
Glutathione S-transferase A2	MAEKPKLHYSNIRGRMESIRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYL...	unknown	inhibitor
Tumor necrosis factor	MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCL...	unknown	inhibitor
Toll-like receptor 9	MGFCRSALHPLSLLVQAIMLAMTLALGTLPAFLPCELQPHGLVNCNWLFL...	unknown	inhibitor
Glutathione S-transferase	MGDNIVLYYFDARGKAELIRLIFAYLGIEYTDKRFGVNGDAFVEFKNFKK...	unknown	inhibitor
High mobility group protein B1	MGKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWK...	unknown	inhibitor
Glutathione S-transferase Mu 1	MPMILGYWDIRGLAHAIRLLLEYTDSSYEEKKYTMGDAPDYDRSQWLNEK...	unknown	inhibitor
Angiotensin-converting enzyme 2	MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNY...	unknown	modulator
Cytochrome P450 2C8	MEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDI...	unknown	substrate
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate
Cytochrome P450 3A5	MDLIPNLAVETWLLLAVSLVLLYLYGTRTHGLFKRLGIPGPTPLPLLGNV...	unknown	substrate
Cytochrome P450 2D6	MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVD...	unknown	substrate,inhibitor
Cytochrome P450 1A1	MLFPISMSATEFLLASVIFCLVFWVIRASRPQVPKGLKNPPGPWGWPLIG...	unknown	substrate
Albumin	MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...	unknown	binder
alpha1-acid glycoprotein	MALSWVLTVLSLLPLLEAQIPLCANLVPVPITNATLDRITGKWFYIASAF...	unknown	binder
ATP-dependent translocase ABCB1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	substrate,inhibitor
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682